The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Abstract
BACKGROUND: The role of orthotopic liver transplantation in the treatment of patients with cirrhosis and hepatocellular carcinoma is controversial, and determining which patients are likely to have a good outcome after liver transplantation is difficult. METHODS: We studied 48 patients with cirrhosis who had small, unresectable hepatocellular carcinomas and who underwent liver transplantation. In 94 percent of the patients, the cirrhosis was related to infection with hepatitis B virus, hepatitis C virus, or both. The presence of tumor was confirmed by biopsy or serum alpha-fetoprotein assay. The criteria for eligibility for transplantation were the presence of a tumor 5 cm or less in diameter in patients with single hepatocellular carcinomas and no more than three tumor nodules, each 3 cm or less in diameter, in patients with multiple tumors. Thirty-three patients with sufficient hepatic function underwent treatment for the tumor, mainly chemoembolization, before transplantation. After liver transplantation, the patients were followed prospectively for a median of 26 months (range, 9 to 54). No anticancer treatment was given after transplantation. RESULTS: The overall mortality rate was 17 percent. After four years, the actuarial survival rate was 75 percent and the rate of recurrence-free survival was 83 percent. Hepatocellular carcinoma recurred in four patients (8 percent). The overall and recurrence-free survival rates at four years among the 35 patients (73 percent of the total) who met the predetermined criteria for the selection of small hepatocellular carcinomas at pathological review of small hepatocellular carcinomas at pathological review of the explanted liver wer 85 percent and 92 percent, respectively, whereas the rates in the 13 patients (27 percent) whose tumors exceeded these limits were 50 percent and 59 percent, respectively (P=0.01 for overall survival; P=0.002 for recurrence-free survival). In this group of 48 patients with early-stage tumors, tumor-node-metastasis status, the number of tumors, the serum alphafetoprotein concentration, treatment received before transplantation, and 10 other variables were not significantly correlated with survival. CONCLUSIONS: Liver transplantation is an effective treatment for small, unresectable hepatocellular carcinomas in patients with cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients
Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T., & Dennison, A. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00005 · Cited by 865
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
Starzl, T. E., Demetris, A. J., Trucco, M., Murase, N., Ricordi, C., Ildstad, S., Ramos, H., Todo, S., Tzakis, A., Fung, J. J., et al. (1993) · Hepatology · doi:10.1002/hep.1840170629 · Cited by 810
Hepatic Resection Versus Transplantation for Hepatocellular Carcinoma
IWATSUKI, S., STARZL, T. E., SHEAHAN, D. G., YOKOYAMA, I., DEMETRIS, A. J., TODO, S., TZAKIS, A. G., VAN THIEL, D. H., CARR, B., SELBY, R., et al. (1991) · Annals of Surgery · doi:10.1097/00000658-199109000-00005 · Cited by 669
Orthotopic Liver Transplantation with Preservation of the Inferior Vena Cava
TZAKIS, A., TODO, S., & STARZL, T. E. (1989) · Annals of Surgery · doi:10.1097/00000658-198911000-00013 · Cited by 621
Ringe, B., Pichlmayr, R., Wittekind, C., & Tusch, G. (1991) · World Journal of Surgery · doi:10.1007/bf01659064 · Cited by 565
Intrahepatic Recurrence After Resection of Hepatocellular Carcinoma Complicating Cirrhosis
BELGHITI, J., PANIS, Y., FAROES, O., BENHAMOU, J. P., & FEKETE, F. (1991) · Annals of Surgery · doi:10.1097/00000658-199108000-00004 · Cited by 562
Role of Liver Transplantation in Cancer Therapy
IWATSUKI, S., GORDON, R. D., SHAW, B. W., & STARZL, T. E. (1985) · Annals of Surgery · doi:10.1097/00000658-198510000-00001 · Cited by 496
Liver Transplantation for Malignant Disease: Results in 93 Consecutive Patients
OʼGRADY, J. G., POLSON, R. J., ROLLES, K., CALNE, R. Y., & WILLIAMS, R. (1988) · Annals of Surgery · doi:10.1097/00000658-198804000-00002 · Cited by 446
Barbara, L., Benzi, G., Gaiani, S., Fusconi, F., Zironi, G., Siringo, S., Rigamonti, A., Barbara, C., Grigioni, W., Mazziotti, A., et al. (1992) · Hepatology · doi:10.1002/hep.1840160122 · Cited by 431
Treatment of Hepatic Coma by Exchange Blood Transfusion
Trey, C., Burns, D. G., & Saunders, S. J. (1966) · New England Journal of Medicine · doi:10.1056/nejm196603032740901 · Cited by 291
Tan, K. C., Rela, M., Ryder, S., et al. (1995) · British journal of surgery · doi:10.1002/bjs.1800820239 · Cited by 100
Liver transplantation for hepatocellular carcinoma
Selby, R. R., Kadry, Z., Cari, B., et al. (1995) · World Journal of Surgery · doi:10.1007/bf00316980 · Cited by 98
Changing concepts: Liver replacement for hereditary tyrosinemia and hepatoma
Starzl, T. E., Zitelli, B. J., Shaw, B. W., Iwatsuki, S., Gartner, J. C., Gordon, R. D., Malatack, J. J., Fox, I. J., Urbach, A. H., & Thiel, D. H. V. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80081-0 · Cited by 58
GNASSI, A. M. (1941) · The American Journal of Surgery · doi:10.1016/s0002-9610(41)90296-9 · Cited by 49
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationLlovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Forner, A., Reig, M., & Bruix, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30010-2 · Cited by 5,531
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Metadata
- Authors
- Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-03-14
- Volume
- 334
- Issue
- 11
- Pages
- 693-700
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2315027248
- Cited by
- 7,186
- References
- 21
- FWCI
- 32.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.